F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to follow physician's order to apply medicated
cream to relieve discomfort and itching for one (R15) of one resident reviewed for quality of care in the
sample of 18.
Residents Affected - Few
Findings include:
R15 was admitted to the facility on [DATE] with diagnosis including but not limited to Essential
Hypertension, Primary Osteoarthritis, Muscle Weakness, Open-Angle Glaucoma Left Eye, and Bilateral
Hearing Loss. According to MDS (Minimum Data Set) dated 09/07/2022 under section C, R15 has BIMS
(Brief Interview of Mental Status) score of 11 indicating moderately impaired cognition.
On 10/24/22 at 11:08 AM the surveyor observed R15 lying in bed, dressed in a hospital gown. The surveyor
asked if R15 usually stays in bed past breakfast. R15 stated, I usually stay in the common area and
participate in activities, but I have had a rash in my private area for months now and it itches terribly. I
stayed in bed because of it in the last two days because it gets worse when I'm sitting down. I would like to
know more about it. V7 (Certified Nursing Assistant) told me that I talk about it too much. Nobody cares
about what I say here. This condition keeps me up at night and it causes pain and itchiness.
On 10/24/22 at 11:38 AM V7 (CNA) stated, I didn't see any rash on her skin. I changed her this morning,
around 7.30 AM. I usually change her every two hours. Surveyor asked if R15 usually stays in bed at this
time. V7 stated, R15 wasn't feeling good yesterday, so today she still didn't feel good and wanted to stay in
bed. Surveyor clarified if V7 discouraged R15 from talking about itchiness in her private area. V7 stated, I
never told her to stop talking about itching, when she mentions something, I always tell her that the nurse
will put some medication on.
On 10/24/22 at 11:45 AM V7 changed R15's briefs and called V6 (Register Nurse) to apply skin barrier
cream into affected area. The surveyor did not note any rash in R15's private area. V7 washed and dressed
R15 and put her into a wheelchair. V7 proceeded to propel R15 into a common area for upcoming lunch.
On 10/24/22 at 12:07 PM V6 (RN) stated, R15 just told me about the itching this morning. I'll notify the
doctor when they do rounds on the unit. We've been using skin barrier cream every time R15 gets her briefs
changed. V6 indicated that she forgot that there was an order of antipruritic cream for R15 private area
itchiness.
On 10/24/2022 at 02:05 PM Surveyor observed V8 (Nurse Practitioner) at R15's bedside. V8 completed
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
145026
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145026
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/27/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Place
3200 Grant Street
Evanston, IL 60201
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
assessment and inquired about the discomfort in R15's private area. Upon completion of R15's
assessment, surveyor asked V8 about R15's private area itchiness. V8 stated, This has been an on and off
going issue. R15 has an order for antipruritic cream to relieve itching in her private area. It has been
ordered for a while. V8 indicated that she is not sure why V6 did not offer it to R15 for symptom relief.
Point of Service plan dated 02/24/2022 reads in part, Estradiol 0.01% (0.1mg/gram) vaginal cream (Cream
with Applicator) Notes: Dx Vaginal Dryness. Frequency: as needed.
R15's Medication Administration Record for October 2022 shows that antipruritic cream was applied only
once, on 10/24/2022 at 12:32 PM, after surveyor interaction with R15, V6 (RN) and V7 (CNA).
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145026
If continuation sheet
Page 2 of 2